Effect of Evolocumab on Lipoprotein(a) and PCSK9 in Healthy Individuals with Elevated Lipoprotein(a) Level

Effect of Evolocumab on Lipoprotein(a) and PCSK9 in Healthy Individuals with Elevated Lipoprotein(a) Level

<b>Background and aims</b>: The aim of this study was to investigate the influence of a single injection of Evolocumab on the dynamics of Lp(a), fractions of apoB100-containing lipoproteins, PCSK9, and their complexes in healthy individuals with elevated Lp(a) levels. <b>Methods<...

Full description

Bibliographic Details
Main Authors: Olga Afanasieva, Marat V. Ezhov, Elena Klesareva, Oksana Razova, Uliana Chubykina, Mane Egiazaryan, Ekaterina Sherstyuk, Marina Afanasieva, Elena Utkina, Sergei Pokrovsky
Format: Article
Language:English
Published: MDPI AG 2020-10-01
Series:Journal of Cardiovascular Development and Disease
Subjects:
lipoprotein(a)
proprotein convertase subtilisin/kexin type 9
Evolocumab
PCSK9-lipoprotein complex
Online Access:https://www.mdpi.com/2308-3425/7/4/45

Internet

https://www.mdpi.com/2308-3425/7/4/45

Similar Items